Analysts Set Option Care Health, Inc. (NASDAQ:OPCH) Target Price at $30.14

Option Care Health, Inc. (NASDAQ:OPCH) has received an average rating of “Hold” from the seven ratings firms that are presently covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $30.14.

OPCH has been the subject of a number of research reports. Barrington Research dropped their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a report on Thursday, October 31st. JMP Securities boosted their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. UBS Group began coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Finally, The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $38.00 to $27.00 in a research report on Monday, November 4th.

Option Care Health Trading Up 1.5 %

OPCH stock opened at $23.15 on Tuesday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company’s 50-day simple moving average is $24.20 and its 200 day simple moving average is $28.06. Option Care Health has a 52 week low of $21.39 and a 52 week high of $34.63. The company has a market capitalization of $3.94 billion, a PE ratio of 19.45, a price-to-earnings-growth ratio of 2.43 and a beta of 1.33.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently modified their holdings of the company. Westfield Capital Management Co. LP increased its position in shares of Option Care Health by 10.2% during the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after buying an additional 599,589 shares during the period. Global Alpha Capital Management Ltd. increased its stake in shares of Option Care Health by 108.3% in the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock worth $1,559,000 after acquiring an additional 25,905 shares in the last quarter. Victory Capital Management Inc. lifted its position in Option Care Health by 4,432.8% during the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after acquiring an additional 1,585,818 shares during the period. Edgestream Partners L.P. grew its holdings in Option Care Health by 96.8% in the second quarter. Edgestream Partners L.P. now owns 351,476 shares of the company’s stock worth $9,736,000 after purchasing an additional 172,845 shares during the period. Finally, Barclays PLC increased its stake in shares of Option Care Health by 180.1% during the third quarter. Barclays PLC now owns 310,194 shares of the company’s stock valued at $9,708,000 after purchasing an additional 199,454 shares in the last quarter. 98.05% of the stock is owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.